dan karlin

cmo @ mindmed | psychiatry, addiction medicine, clinical informatics

[Brandon Weiss @BWe1ss]

On Tuesday October 28th, I joined Marcus Capone ((Ret.) Navy SEAL and Founder of VETS and Tara Mind), Dr. Dan Karlin @dankarlin (CMO of MindMed), and Dr. Lynnette Averill (Associate Professor of Baylor College of Medicine) in speaking to an audience of healthcare services executives about the nature of psychedelic therapy and experience for Military Veterans. I was also able to share more about our center's @JHPsychedelics program dedicated to understanding the potential of psychedelic therapies for bridging the tragic gap in effective posttraumatic stress disorder treatment for Veterans and all others. We've nearly completed our pilot study and will be able to share very interesting updates in the new year. We heard this panel was a highlight of the Summit. Thank you to Claire Manneh and Datavant for so graciously making space for this dialogue.

[Ordinary Unhappiness @UnhappinessPod]

🚨NEW EPISODE🚨 How do perception and language shape subjectivity? What makes an experience ineffable? And can LSD offer new prospects for treating MDD and GAD? We're joined by @dankarlin of @mindmedco to talk new research trials, neurobiology, and more! https://t.co/N83WGXNtXq

[dan karlin @dankarlin]

I’m looking forward to joining colleagues and innovators at Fierce Biotech Week 2025 in Boston for three days of strategy, science, and conversations shaping the future of biotech.
Dates:  October 7–9
Location: Encore Boston Harbor
#FierceBiotechWeek2025 #Biotech #Innovation

[Definium Therapeutics @definiumtx]

We announced the first patient dosed in our Phase 3 Voyage study evaluating MM120 ODT for generalized anxiety disorder. Thanks to our investigators, clinical trial sites & patients who will enroll in this groundbreaking research. More: https://t.co/ELRPr6tTIK